Major pitfalls in the measurement of artemisinin derivatives in plasma in clinical studies.

Major pitfalls in the measurement of artemisinin derivatives in plasma in clinical studies.

A bioanalytical method for the analysis of artesunate (ARS) and its metabolite dihydroartemisinin (DHA) in human plasma using protein precipitation and liquid chromatography coupled to positive tandem mass spectroscopy was developed. The method was validated according to published US FDA-guidelines...

書誌詳細
主要な著者:	Lindegardh, N, Hanpithakpong, W, Kamanikom, B, Singhasivanon, P, Socheat, D, Yi, P, Dondorp, A, Mcgready, R, Nosten, F, White, N, Day, N
フォーマット:	Journal article
言語:	English
出版事項:	2008

類似資料

Quantification of dihydroartemisinin, artesunate and artemisinin in human blood: overcoming the technical challenge of protecting the peroxide bridge.
著者:: Lindegardh, N, 等
出版事項: (2011)

A liquid chromatographic-tandem mass spectrometric method for determination of artesunate and its metabolite dihydroartemisinin in human plasma.
著者:: Hanpithakpong, W, 等
出版事項: (2008)

A liquid chromatographic-tandem mass spectrometric method for determination of artemether and its metabolite dihydroartemisinin in human plasma.
著者:: Hanpithakpong, W, 等
出版事項: (2009)

Quantification of the anti-influenza drug zanamivir in plasma using high-throughput HILIC-MS/MS.
著者:: Lindegardh, N, 等
出版事項: (2011)

Artemisinin resistance in Plasmodium falciparum malaria.
著者:: Dondorp, A, 等
出版事項: (2009)

Intrahost modeling of artemisinin resistance in Plasmodium falciparum
著者:: Saralamba, S, 等
出版事項: (2010)

Intrahost modeling of artemisinin resistance in Plasmodium falciparum.
著者:: Saralamba, S, 等
出版事項: (2011)

Quantification of artemisinin in human plasma using liquid chromatography coupled to tandem mass spectrometry.
著者:: Lindegardh, N, 等
出版事項: (2009)

Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of oseltamivir and its metabolite oseltamivir carboxylate in plasma, saliva and urine.
著者:: Lindegårdh, N, 等
出版事項: (2007)

Artemisinin Resistance in Plasmodium falciparum Malaria (vol 361, pg 455, 2009)
著者:: Dondorp, A, 等
出版事項: (2009)

Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria.
著者:: Das, D, 等
出版事項: (2013)

Artemisinin resistance: current status and scenarios for containment.
著者:: Dondorp, A, 等
出版事項: (2010)

Intrarectal artemisinin derivatives.
著者:: Nosten, F, 等
出版事項: (1998)

Emergence of artemisinin-resistant malaria on the western border of Thailand: A longitudinal study
著者:: Phyo, A, 等
出版事項: (2012)

Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study.
著者:: Phyo, A, 等
出版事項: (2012)

Laboratory detection of artemisinin-resistant Plasmodium falciparum.
著者:: Chotivanich, K, 等
出版事項: (2014)

Development and validation of a high-throughput zwitterionic hydrophilic interaction liquid chromatography solid-phase extraction-liquid chromatography-tandem mass spectrometry method for determination of the anti-influenza drug peramivir in plasma.
著者:: Lindegardh, N, 等
出版事項: (2008)

Artemisinin Resistance in Plasmodium falciparum Malaria REPLY
著者:: Dondorp, A, 等
出版事項: (2009)

Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study
著者:: Phyo, A, 等
出版事項: (2012)

Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
著者:: Tarning, J, 等
出版事項: (2009)

Use of artemisinin derivatives for the control of malaria.
著者:: Nosten, F, 等
出版事項: (1998)

Artemisinin derivatives in the treatment of falciparum malaria in pregnancy.
著者:: Mcgready, R, 等
出版事項: (1998)

Validation and application of a liquid chromatographic-mass spectrometric method for determination of artesunate in pharmaceutical samples.
著者:: Lindegårdh, N, 等
出版事項: (2007)

Plasmodium falciparum-based bioassay for measurement of artemisinin derivatives in plasma or serum.
著者:: Teja-Isavadharm, P, 等
出版事項: (2004)

Artemisinin resistance: current status and scenarios for containment (vol 8, pg 272, 2010)
著者:: Dondorp, A, 等
出版事項: (2010)

Population pharmacokinetic and pharmacodynamic modeling of artemisinin resistance in Southeast Asia
著者:: Lohy Das, J, 等
出版事項: (2017)

A major genome region underlying artemisinin resistance in malaria.
著者:: Cheeseman, I, 等
出版事項: (2012)

Exploring the contribution of candidate genes to artemisinin resistance in Plasmodium falciparum.
著者:: Imwong, M, 等
出版事項: (2010)

A major genome region underlying artemisinin resistance in malaria.
著者:: Cheeseman, I, 等
出版事項: (2012)

Studies of the neurotoxicity of oral artemisinin derivatives in mice.
著者:: Nontprasert, A, 等
出版事項: (2000)

Pitfalls in estimating piperaquine elimination.
著者:: Tarning, J, 等
出版事項: (2005)

Optimising strategies for Plasmodium falciparum malaria elimination in Cambodia: primaquine, mass drug administration and artemisinin resistance.
著者:: Maude, R, 等
出版事項: (2012)

Rapid degradation of oseltamivir phosphate in clinical samples by plasma esterases.
著者:: Lindegardh, N, 等
出版事項: (2006)

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria.
著者:: Ashley, E, 等
出版事項: (2010)

Artemisinin resistance in Plasmodium falciparum is associated with an altered temporal pattern of transcription.
著者:: Mok, S, 等
出版事項: (2011)

Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
著者:: Tarning, J, 等
出版事項: (2012)

Neuropathologic toxicity of artemisinin derivatives in a mouse model.
著者:: Nontprasert, A, 等
出版事項: (2002)

Assessment of the neurotoxicity of parenteral artemisinin derivatives in mice.
著者:: Nontprasert, A, 等
出版事項: (1998)

Effects of artemisinin derivatives on malaria transmissibility.
著者:: Price, R, 等
出版事項: (1996)

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria
著者:: Ashley, E, 等
出版事項: (2010)